Deborah L. Keller
CIK: 0001352992
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
WST
WEST PHARMACEUTICAL SERVICES INC
Director
Discretionary Trading P&L
Holdings
About Keller Deborah L
Keller Deborah L (SEC CIK 0001352992) files insider reports with the SEC as Director of WEST PHARMACEUTICAL SERVICES INC (WST).
Signal8 holds 2 ownership filings by Keller Deborah L, all Form 4s, filed between May 8, 2025 and May 6, 2026. Those filings report 2 transactions, from May 6, 2025 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Keller Deborah L's filings is in EXTON, PA.
Recent filings by Keller Deborah L
Other insiders filing for WEST PHARMACEUTICAL SERVICES INC (WST)
- HAUGEN JANET BRUTSCHEA, Director
- Favorite Annette F, Sr. VP & Chief HR Officer
- Lagarde Michel, President and CEO
- McMahon Robert W., SVP & Chief Financial Officer
- Campbell Shane Alden, SVP, Proprietary Segment
- Pucci Paolo, Director